Franklin Resources
COGT icon

Franklin Resources’s Cogent Biosciences COGT Stock Holding History

Franklin Resources’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.3M Buy
162,785
+138,432
+568% +$4.84M ﹤0.01% 1488
2026
Q1 		$937K Buy
+24,353
New +$899K ﹤0.01% 2209
2025
Q2 		– Sell
-1,326,431
Closed -$7.95M – 3047
2025
Q1 		$7.95M Buy
1,326,431
+42,758
+3% +$335K ﹤0.01% 1174
2024
Q4 		$10M Buy
1,283,673
+283,506
+28% +$2.83M ﹤0.01% 1123
2024
Q3 		$11.3M Buy
1,000,167
+51
+0% +$497 ﹤0.01% 1075
2024
Q2 		$8.43M Buy
+1,000,116
New +$7.59M ﹤0.01% 1134
2022
Q1 		– Sell
-53,600
Closed -$460K – 2453
2021
Q4 		$460K Sell
53,600
-900
-2% -$7.82K ﹤0.01% 1933
2021
Q3 		$458K Buy
+54,500
New +$418K ﹤0.01% 1920

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources's COGT Position: Q2 2026 in Review

Franklin Resources increased its Cogent Biosciences (COGT) stake by 568% in Q2 2026, buying an estimated $4.84M and bringing the position to 162,785 shares worth $6.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

Franklin Resources first reported a position in COGT in Q3 2021 and has held it in 8 quarters since. The position peaked at $11.3M in Q3 2024. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Franklin Resources held 162,785 shares of Cogent Biosciences worth $6.3M as of Q2 2026.
  • Franklin Resources bought 138,432 Cogent Biosciences shares in Q2 2026, an estimated $4.84M.
  • Cogent Biosciences made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1488 holding.
  • Franklin Resources first reported a position in Cogent Biosciences in Q3 2021 and has held it in 8 quarters since.
  • Franklin Resources's Cogent Biosciences position peaked at $11.3M in Q3 2024.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.